Canopy Growth Corp vs PepsiCo, Inc. — how do they compare? Canopy Growth Corp trades at $0.96 (market cap $398.46M), while PepsiCo, Inc. trades at $135.66 (market cap $184.87B). The key difference: PepsiCo, Inc. is far larger — about 464× Canopy Growth Corp's market cap, and PepsiCo, Inc. pays a 4.37% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | PEP | |
|---|---|---|
Market Cap | $398.46M | $184.87B |
Sector | Health | Consumer Staples |
52-Week High | $1.92 | $170.44 |
52-Week Low | $0.86 | $133.81 |
Enterprise Value | $337.90M | $227.37B |
Dividend Yield | — | 4.37% |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
PepsiCo (PEP) trades at $135.45, down 2.2% on the day, with a bearish technical signal from moving averages but oversold short-term RSI. The company reported revenue of $93.93B for 2025 and has beaten EPS estimates for three consecutive quarters. Recent news highlights price cuts on snacks like Doritos to address consumer pushback, while institutional investors show mixed activity.
The stock offers a forward dividend yield near 4% and trades below the consensus price target of $159.27, suggesting potential upside. Risks include execution of the North American turnaround and margin pressure from pricing strategies. Analyst sentiment is cautious with a majority Hold rating, reflecting near-term uncertainty amid strategic shifts.
Trailing returns across standard periods
Latest headlines on both assets
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →